To understand the molecular pathways that affect cellular sensitivity to tankyrase inhibitors, we established a novel tankyrase inhibitor-resistant cell line, 320-IWR, from Wnt/β-catenin-dependent CRC COLO-320DM cells. The gene discussed is TNKS; the disease is colorectal carcinoma.